• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cybercrime: RSA Security’s bout with poison ivy

Cybercrime: RSA Security’s bout with poison ivy

April 16, 2011 By MassDevice Contributors Network

Dr. John Halamka

By John D. Halamka, MD

I’ve worked with RSA Security, the security division of EMC Corp. (NYSE:EMC) since my days as an informatics fellow when I first used SecurIDs as part of my early health information exchange work.

Just as I was transparent about the CareGroup Network Outage in 2002, RSA has shared all the details of their recent security breach.

It all started with a well crafted phishing email to a non-technical staff member with the subject line “2011 recruitment plan”.

Attached to the email was an excel spreadsheet that contained an exploit for a known vulnerability in Adobe Flash.

The exploit installed a hard-to-detect remote administration tool named Poison Ivy on at least one RSA computer. The end result was that an attacker gained access to the RSA network.

The attackers moved from system to system harvesting accounts until they came across those users who had highly privileged access to sensitive systems and data.

An internal staging system was “created” to collect, encrypt and transmit back up lists of usernames/passwords to systems.

Confidential material related to SecurID technology was FTPed to a remote site.

The attackers have not been identified.

The attack was remarkably sophisticated and illustrates the evolution of cybercrime over the past 10 years. Here are the 4 principle stages:

1st Generation – Because I can
Worms, defacement of web sites

2nd Generation – I can make money
Botnets appear, denial of service attacks, seeking payment to stop attacks

3rd Generation – Organized crime
Large scale management of attacks, coordinated use of tools and techniques, trojans, worms Phishing, targeted attacks

4th Generation – Selling the tools
Tools to perform attacks become “vended” with 24/7 support available, Botnet rentals, sophisticated Id theft services, Licensed Malware appears, Exploit knowledge is sold. Social Networks just for cybercriminals appear. Cybercrime supply chains are formalized and fine tuned.

I’ve described security as a Cold War – the faster we implement protections, the faster the cybercriminals innovate.

Thanks to RSA for sharing their experience with the rest of the industry.

Filed Under: Health Information Technology, News Well, Software / IT Tagged With: EMC Corp., Harvard Medical School, Life as a Health Care CIO

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy